ADMA Biologics, Inc. (NASDAQ: ADMA) made a significant announcement in a recent Securities and Exchange Commission filing. On December 30, 2024, the Company’s Board of Directors appointed Eduardo Rene ...
With over 20 years of senior executive and consulting experience, Ms. Volpone has driven shareholder value for more than 300 publicly traded companies through capital markets strategy, corporate ...
NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Nixxy, Inc, (Nasdaq:NIXX), or "the Company," today announced the appointment of Debra Chen Volpone as Chief Executive Officer and a member of the Board, e ...